Mosaic Biosciences Secures Financing From Telegraph Hill Partners To Support Commercial Growth And Expand Drug Discovery Capabilities And Services
Jun 14, 2022•about 3 years ago
Description
Mosaic Biosciences (“Mosaic” or “the Company”), a protein and antibody discovery company that helps its partners identify next-generation therapies for the prevention and treatment of disease. announced the closing of a $11.4 million financing led by Telegraph Hill Partners (“THP”), a life science venture capital and growth equity firm based in San Francisco, CA. Dan Mitchell, a Boulder-based venture capitalist, also participated in the financing.